Akari Therapeutics, Plc, an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Multiple departments, including engineering and quality assurance, are responsible for evaluating GMP equipment and ...

Small drugmakers seek deadline extension for GMP compliance as December 2025 approaches, emphasizing the need for support and ...

Corona Remedies announces commencement of capacity expansion for commercial production at Bhayla facility: Our Bureau, Mumbai Monday, December 29, 2025, 13:30 Hrs [IST] Corona Rem ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, today ...

The health ministry is unlikely to extend the Schedule M deadline for MSME pharma firms beyond December 31, 2025, as it ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) on Monday announced program updates on TNX-4800 (formerly known as mAb 2217LS), a long-acting human monoclonal antibody (mAb) that targets the outer ...

About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...

Akari Therapeutics (AKTX) announced the initiation of GMP manufacturing activities to support the development of AKTX-101, the Company’s lead ADC ...

The IPO listing date has been tentatively fixed as Dec. 31. Shares of Apollo Techno Industries will be listed on the BSE SME ...